Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
Top Cited Papers
Open Access
- 1 April 2005
- Vol. 54 (4) , 533-539
- https://doi.org/10.1136/gut.2004.052167
Abstract
Background: Diabetes has been associated with an increased risk of hepatocellular carcinoma (HCC) in studies of referred patients. This is the first population based case control study in the USA to examine this association while adjusting for other major risk factors related to HCC. Methods: We used the Surveillance Epidemiology and End-Results Program (SEER)-Medicare linked database to identify patients aged 65 years and older diagnosed with HCC and randomly selected non-cancer controls between 1994 and 1999. Only cases and controls with continuous Medicare enrolment for three years prior to the index date were examined. Inpatient and outpatient claims files were searched for diagnostic codes indicative of diabetes, hepatitis C virus (HCV), hepatitis B virus (HBV), alcoholic liver disease, and haemochromatosis. HCC patients without these conditions were categorised as idiopathic. Unadjusted and adjusted odds ratios were calculated in logistic regression analyses. Results: We identified 2061 HCC patients and 6183 non-cancer controls. Compared with non-cancer controls, patients with HCC were male (66% v 36%) and non-White (34% v 18%). The proportion of HCC patients with diabetes (43%) was significantly greater than non-cancer controls (19%). In multiple logistic regression analyses that adjusted for demographics features and other HCC risk factors (HCV, HBV, alcoholic liver disease, and haemochromatosis), diabetes was associated with a threefold increase in the risk of HCC. In a subset of patients without these major risk factors, the adjusted odds ratio for diabetes declined but remained significant (adjusted odds ratio 2.87 (95% confidence interval 2.49–3.30)). A significant positive interaction between HCV and diabetes was detected (pConclusions: Diabetes is associated with a 2–3-fold increase in the risk of HCC, regardless of the presence of other major HCC risk factors. Findings from this population based study suggest that diabetes is an independent risk factor for HCC.Keywords
This publication has 20 references indexed in Scilit:
- The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An UpdateAnnals of Internal Medicine, 2003
- Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitusHepatology, 2002
- Rising Prevalence of Hepatitis C Virus Infection Among Patients Recently Diagnosed With Hepatocellular Carcinoma in the United StatesJournal of Clinical Gastroenterology, 2002
- Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.Published by Rockefeller University Press ,2002
- Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinomaGastroenterology, 2002
- Prospective study of diabetes mellitus and liver cancer in JapanDiabetes/Metabolism Research and Reviews, 2001
- Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely ObeseGastroenterology, 2001
- Risk Factors for the Rising Rates of Primary Liver Cancer in the United StatesArchives of internal medicine (1960), 2000
- Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantationHepatology, 2000
- Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitisHepatology, 1999